SWHR Responds to RFI on Clinical Research Infrastructure and Emergency Clinical Trials
SWHR submitted comments to the White House Office of Science and Technology Policy (OSTP) on a Request for Information (RFI) on Clinical Research Infrastructure and Emergency Clinical Trials. To enhance the U.S. clinical trial infrastructure, SWHR encouraged OSTP to ensure the inclusion of pregnant and lactating populations in clinical trials, to enhance representation of underrepresented populations, and to support the participation of different communities through clinical trial site locations.
SWHR submitted comments to the White House Office of Science and Technology Policy (OSTP) on a Request for Information (RFI) on Clinical Research Infrastructure and Emergency Clinical Trials. To enhance the U.S. clinical trial infrastructure, SWHR encouraged OSTP to ensure the inclusion of pregnant and lactating populations in clinical trials, to enhance representation of underrepresented populations, and to support the participation of different communities through clinical trial site locations.